Omnicell is growing its portfolio of medication management solutions and adherence tools. The Mountain View, Calif.-based company has entered into a definitive agreement with pharmacy software solutions provider FDS Amplicare to acquire its business for $177 million.
The company said the acquisition would add FDS Amplicare's financial management, analytics, and population health solutions to Omnicell’s EnlivenHealth division, growing its pharmacy offerings meant to improve health outcomes and enable new clinical services. In particular, Omnicell said FDS Amplicare's reconciliation, medical claims processing, payment collection and distribution, adherence-tracking and store performance monitoring tools were among those that will complement EnlivenHealth's existing offering.
“We are thrilled to be joining together two innovative technology leaders whose shared mission is to transform both the practice and business of retail pharmacy,” said Randall Lipps, chairman, president, CEO, and founder of Omnicell. “We believe the combination of EnlivenHealth’s leading patient engagement and communications solutions with FDS Amplicare’s financial management, analytics, and population health solutions, strengthens our advanced services portfolio, and is another step to deliver solutions that support the long-term vision and opportunity of the fully autonomous pharmacy.”
Omnicell said the addition of FDS Amplicare’s solutions is expected to strengthen EnlivenHealth’s offerings to give pharmacies the tools and intelligence they need to manage, forecast, and mitigate direct & indirect remuneration, or DIR fees.
"The COVID-19 pandemic has accelerated the transformation to the New Era Pharmacy,” said Adam McMullin, FDS Amplicare CEO. “Pharmacies are responding to the growing demand for accessible, trusted community healthcare by stepping up their offering of high-value clinical services such as vaccinations and point-of-care testing. As we looked at the best way to enable pharmacy and serve our customers, joining together with Omnicell’s EnlivenHealth division was clearly the best path to provide more innovative and comprehensive solutions designed to enhance the success of retail pharmacy today and into the future."
EnlivenHealth has a growing business providing technology solutions that enable retail pharmacies and their health plan partners to measurably improve medication adherence, increase quality measures and drive business results. FDS Amplicare’s population health management solutions are expected to help to accelerate the combined entity’s growth in the health plan market, which continues to grow rapidly due to major economic and demographic trends such as the aging population.
“FDS Amplicare adds strong new capabilities to our EnlivenHealth portfolio intended to drive clinical, workflow, and financial growth opportunities for our growing base of pharmacy partners,” said Danny Sanchez, vice president and general manager of EnlivenHealth. “The addition of FDS Amplicare’s nationwide network of independent retail pharmacies significantly expands EnlivenHealth’s broad industry footprint centered on leading pharmacy chains. Equally important, this combination is expected to strengthen our offering of advanced digital technology solutions, empowering pharmacies and their health plan partners to ensure the lifelong optimal health of their patients and members, while maximizing business results.”
The FDS Amplicare business that is being acquired had roughly $29 million of total revenue for the 12 months ended June 30. The transaction is expected to close in the second half of 2021.